The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genetic landscape of resistance to CDK4/6 inhibition in circulating tumor DNA (ctDNA) analysis of the PALOMA3 trial of palbociclib and fulvestrant versus placebo and fulvestrant.
 
Nicholas C. Turner
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Puma Biotechnology; Roche; Synthon; Tesaro
Research Funding - AstraZeneca (Inst); Bio-Rad (Inst); Clovis Oncology (Inst); Inivata (Inst); Pfizer (Inst); Roche (Inst)
 
Ben O'Leary
Research Funding - Pfizer (Inst)
 
Ros Cutts
No Relationships to Disclose
 
Yuan Liu
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Sarah Hrebien
No Relationships to Disclose
 
Xin Huang
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Matthew Beaney
Stock and Other Ownership Interests - Randox (I)
 
Kerry Fenwick
No Relationships to Disclose
 
Fabrice Andre
Research Funding - AstraZeneca (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Novartis; Roche
 
Sibylle Loibl
Honoraria - Pfizer; Roche
Consulting or Advisory Role - Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Teva (Inst); Vifor Pharma (Inst)
 
Sherene Loi
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - PI3K pathway gene signature granted by the European and US patent offices (Inst)
 
Isaac Garcia-Murillas
No Relationships to Disclose
 
Cynthia Huang Bartlett
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Massimo Cristofanilli
Honoraria - Dompé Farmaceutici; Pfizer
Consulting or Advisory Role - Dompé Farmaceutici; Newomics; Vortex Biosciences